Agomab Welcomes Angelika Jahreis as Member of the BOD And Andrea Sáez As CDO
Agomab Therapeutics NV, a company developing differentiated programs with disease-modifying potential in fibrotic diseases, announced recently the appointment of Angelika Jahreis, MD, PhD, as an independent non-executive director to Agomab’s Board of Directors (BOD), while Andrea Sáez, PhD, will join Agomab’s executive leadership team as Chief Development Officer (CDO). Industry sources also added that Paolo […]
